Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.

Autor: de Ranitz-Greven WL, Kaasenbrood L, Poucki WK, Hamerling J, Bos DC, Visser GH, Biesma DH, Beulens JW, de Valk HW

Publikováno v: Diabetes Technology & Therapeutics; 2012 Dec, Vol. 14 Issue 12, p1134-1139, 6p

Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.

Autor: Bos DC, de Ranitz-Greven WL, de Valk HW

Publikováno v: Diabetes Technology & Therapeutics; 2011 Jul, Vol. 13 Issue 7, p773-779, 7p

HbA 1c and fasting plasma glucose levels are equally related to incident cardiovascular risk in a high CVD risk population without known diabetes.

Autor: Been RA; Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Noordstar E; Department of Internal Medicine, Isala Hospital, Zwolle, The Netherlands., Helmink MAG; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., van Sloten TT; Department of Endocrinology, University Medical Center Utrecht, Utrecht, The Netherlands., de Ranitz-Greven WL; Department of Endocrinology, University Medical Center Utrecht, Utrecht, The Netherlands., van Beek AP; Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Houweling ST; Langerhans Foundation, Zeist, The Netherlands., van Dijk PR; Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Westerink J; Department of Internal Medicine, Isala Hospital, Zwolle, The Netherlands.

Publikováno v: Diagnosis (Berlin, Germany) [Diagnosis (Berl)] 2024 Feb 29; Vol. 11 (3), pp. 312-320. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).

Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.

Autor: Müller AR; 'S Heeren Loo, Amersfoort, The Netherlands.; Emma Center for Personalized Medicine, Department of Pediatrics, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, Amsterdam, The Netherlands.; Amsterdam Public Health Research Institute, Methodology and Mental Health and Personalized Medicine, Amsterdam, The Netherlands., Luijten MAJ; Amsterdam Public Health Research Institute, Methodology and Mental Health and Personalized Medicine, Amsterdam, The Netherlands.; Department of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Reproduction & Development, Child Development, Amsterdam, The Netherlands., Haverman L; Amsterdam Public Health Research Institute, Methodology and Mental Health and Personalized Medicine, Amsterdam, The Netherlands.; Department of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Reproduction & Development, Child Development, Amsterdam, The Netherlands., de Ranitz-Greven WL; Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Janssens P; Department of Nephrology and Arterial Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium., Rietman AB; Department of Child and Adolescent Psychiatry/Psychology and ENCORE Expertise Center, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands., Hoopen LWT; Department of Child and Adolescent Psychiatry/Psychology and ENCORE Expertise Center, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., de Graaff LCG; Center for Adults With Rare Genetic Syndromes, Division of Endocrinology, Department of Internal Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., de Wit MC; Department of Pediatric Neurology and ENCORE Expertise Center, Erasmus Medical Center Sophia Children's Hospital, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Jansen AC; Neurogenetics Research Group, Reproduction Genetics and Regenerative Medicine Research Cluster, Vrije Universiteit Brussel, Brussels, Belgium.; Pediatric Neurology Unit, Department of Pediatrics, Antwerp University Hospital, Translational Neurosciences, University of Antwerp, Antwerp, Belgium., Gipson T; Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, TN, USA.; Le Bonheur Children's Hospital and Boling Center for Developmental Disabilities, Memphis, TN, USA., Capal JK; Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., de Vries PJ; Centre for Autism Research in Africa (CARA), Division of Child & Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa., van Eeghen AM; 'S Heeren Loo, Amersfoort, The Netherlands. a.m.vaneeghen@amsterdamumc.nl.; Emma Center for Personalized Medicine, Department of Pediatrics, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. a.m.vaneeghen@amsterdamumc.nl.; Amsterdam Public Health Research Institute, Methodology and Mental Health and Personalized Medicine, Amsterdam, The Netherlands. a.m.vaneeghen@amsterdamumc.nl.; Amsterdam Reproduction & Development, Child Development, Amsterdam, The Netherlands. a.m.vaneeghen@amsterdamumc.nl.

Publikováno v: BMC medicine [BMC Med] 2023 Oct 23; Vol. 21 (1), pp. 401. Date of Electronic Publication: 2023 Oct 23.